Sarah Cleary

Monday 1st July 2024, 14:45-15:45
Biocatalytic hydrogenation: robust biotechnologies for sustainable chemical manufacturing

Sarah is Chief Scientific Officer and Co-founder of HydRegen Ltd, and has a passion for innovation and sustainability. She earned her PhD in organic chemistry from the University of Vermont (USA), focusing on synthetic methodologies in Prof. Matthias Brewer’s group. She then joined Prof. Kylie Vincent’s group at the University of Oxford as a postdoc, where she helped develop biocatalytic hydrogenation technologies, from innovation to de-risking for commercialisation. Sarah, alongside Dr Holly Reeve and Prof. Vincent, co-founded HydRegen which, at its core, is a process company that builds tools to make biocatalysis more straightforward to implement in chemistry settings. The HydRegen biotechnologies provide sustainable manufacturing solutions across the chemicals sector. Recent highlights include the validation of HydRegen’s core technology, H2BioCat, in typical batch and continuous flow hydrogenation infrastructure, demonstrating feasibility for process scale-up of speciality chemical manufacturing. 


Visit us on Social Media

Please note: All information requested on the website and registration process is strictly for the use of the Congress in compliance with international privacy legislation. By completing this registration form you will agree that the Congress will use this data to keep you fully informed of the Congress in 2024. The data will then be retained by the Congress secretariat for the purposes of informing you about activities and future meetings. On the registration form, You will also have the opportunity to agree separately to allow key data (Name, Company, Email Address) to be shared with sponsors and exhibitors who are participating in the Congress in 2024. We will not pass any details to any companies not participating in the Congress in 2024.